Found: 22
Select item for more details and to access through your institution.
Neuroendocrine Tumors: a Relevant Clinical Update.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 6, p. 703, doi. 10.1007/s11912-022-01217-z
- By:
- Publication type:
- Article
Clinical benefit of palliative radiation therapy in advanced gastric cancer.
- Published in:
- Acta Oncologica, 2008, v. 47, n. 3, p. 421, doi. 10.1080/02841860701621233
- By:
- Publication type:
- Article
Chromogranin A and Neuron-Specific Enolase as Prognostic Markers in Patients with Advanced pNET Treated with Everolimus.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 12, p. 3741, doi. 10.1210/jc.2011-0666
- By:
- Publication type:
- Article
Molecular Pathways and Targeted Therapy in Cholangiocarcinoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2019, v. 17, n. 11, p. 630
- By:
- Publication type:
- Article
Stereotactic Body Radiation Therapy and Immunotherapy.
- Published in:
- Clinical Advances in Hematology & Oncology, 2019, v. 17, n. 9, p. 518
- By:
- Publication type:
- Article
The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumors.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 10, p. 2953, doi. 10.1002/cam4.742
- By:
- Publication type:
- Article
Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Epidemiological risk factors for adrenocortical carcinoma: A hospital‐based case–control study.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 7, p. 1836, doi. 10.1002/ijc.32534
- By:
- Publication type:
- Article
Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study.
- Published in:
- Endocrine (1355008X), 2021, v. 71, n. 2, p. 502, doi. 10.1007/s12020-020-02475-2
- By:
- Publication type:
- Article
Recent Advances in the Management of Gastroenteropancreatic Neuroendocrine Tumors: Discussion.
- Published in:
- Clinical Advances in Hematology & Oncology, 2017, v. 15, n. S4, p. 18
- By:
- Publication type:
- Article
Emerging Treatment Options for Patients With Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Clinical Advances in Hematology & Oncology, 2017, v. 15, n. S4, p. 10
- By:
- Publication type:
- Article
Recent Advances in the Management of Gastroenteropancreatic Neuroendocrine Tumors: Insights From the 2017 ASCO Gastrointestinal Cancers Symposium.
- Published in:
- Clinical Advances in Hematology & Oncology, 2017, v. 15, n. S4, p. 1
- By:
- Publication type:
- Article
Highlights in GEP-NETs From the 2016 American Society of Clinical Oncology Gastrointestinal Cancers Symposium: Commentary.
- Published in:
- Clinical Advances in Hematology & Oncology, 2016, v. 14, p. 18
- By:
- Publication type:
- Article
Highlights in GEP-NETs From the 2015 American Society of Clinical Oncology Annual Meeting: Commentary.
- Published in:
- Clinical Advances in Hematology & Oncology, 2015, v. 13, p. 17
- By:
- Publication type:
- Article
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Clinical Advances in Hematology & Oncology, 2014, v. 12, n. 12, p. 3
- By:
- Publication type:
- Article
Trimodality Therapy Without a Platinum Compound for Localized Carcinoma of the Esophagus and Gastroesophageal Junction.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 7, p. 1656, doi. 10.1002/cncr.24935
- By:
- Publication type:
- Article
Effect of Lanreotide Depot/Autogel on Urinary 5‐Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 463, doi. 10.1634/theoncologist.2018-0217
- By:
- Publication type:
- Article
Next-Generation Sequencing of Matched Primary and Metastatic Rectal Adenocarcinomas Demonstrates Minimal Mutation Gain and Concordance to Colonic Adenocarcinomas.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2016, v. 140, n. 6, p. 529, doi. 10.5858/arpa.2015-0261-SA
- By:
- Publication type:
- Article
A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-561
- By:
- Publication type:
- Article
Neuroendocrine Tumors and Lanreotide Depot: Clinical Considerations and Nurse and Patient Preferences.
- Published in:
- Clinical Journal of Oncology Nursing, 2016, v. 20, n. 6, p. E139, doi. 10.1188/16.CJON.E139-E146
- By:
- Publication type:
- Article
Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals.
- Published in:
- ClinicoEconomics & Outcomes Research, 2017, v. 9, p. 495, doi. 10.2147/CEOR.S140866
- By:
- Publication type:
- Article
A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers.
- Published in:
- 2014
- By:
- Publication type:
- journal article